Robert Driscoll Score: 33
Analyst at
Wedbush
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-3.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
46%
11 W / 13 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
69%
9 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
43%
9 W / 12 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
37%
7 W / 12 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
80%
4 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 02, 2026 |
Foghorn Therapeutics Inc
FHTX
|
SELL |
$2.00
Est. +32%
|
$2.92 | $1.80 (Low) |
Target Met
|
$2.10
+28.1%
|
| Sep 22, 2026 |
Compass Therapeutics Inc
CMPX
|
SELL |
$1.00
Est. +19%
|
$1.24 | $0.73 (Low) |
Target Met
|
$0.78
+37.5%
|
| Sep 10, 2026 |
Pyxis Oncology Inc
PYXS
|
BUY |
$8.00
Est. +137%
|
$3.38 | $3.52 |
Pending
|
$1.66
-50.9%
|
| Aug 07, 2026 |
Replimune Group Inc
REPL
|
BUY |
$19.00
Est. +48%
|
$12.86 | $21.26 |
Target Met
|
$20.69
+60.9%
|
| Aug 05, 2026 |
Arvinas Inc
ARVN
|
BUY |
$12.00
Est. +33%
|
$9.00 | $9.74 |
Pending
|
$7.42
-17.6%
|
| Aug 03, 2026 |
Monte Rosa Therapeutics Inc
GLUE
|
BUY |
$27.00
Est. +67%
|
$16.17 | $17.13 |
Pending
|
$10.82
-33.1%
|
| Jul 31, 2026 |
Replimune Group Inc
REPL
|
BUY |
$12.00
Est. +122%
|
$5.41 | $21.26 |
Target Met
|
$20.69
+282.4%
|
| Jul 23, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$192.10
Est. +1%
|
$190.94 | $224.31 |
Target Met
|
$199.70
+4.6%
|
| May 05, 2026 |
Pyxis Oncology Inc
PYXS
|
BUY |
$6.00
Est. +241%
|
$1.76 | $4.12 |
Pending
|
$1.66
-5.7%
|
| Feb 13, 2026 |
Tyra Biosciences Inc
TYRA
|
BUY |
$53.00
Est. +76%
|
$30.10 | $40.65 |
Pending
|
$21.53
-28.5%
|
| Dec 16, 2025 |
Tyra Biosciences Inc
TYRA
|
BUY |
$37.00
Est. +67%
|
$22.11 | $40.65 |
Target Met
|
$21.53
-2.6%
|
| Dec 09, 2025 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$34.00
Est. +179%
|
$12.18 | $23.19 |
Pending
|
$12.49
+2.5%
|
| Aug 15, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$25.00
Est. +187%
|
$8.72 | $22.50 |
Miss
|
$1.27
-85.4%
|
| Aug 08, 2024 |
Tango Therapeutics Inc
TNGX
|
BUY |
$13.00
Est. +49%
|
$8.72 | $12.02 |
Miss
|
$23.18
+165.8%
|
| Jul 15, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$59.00
Est. +26%
|
$47.01 | $62.40 |
Target Met
|
$199.70
+324.8%
|
| Jun 18, 2024 |
Zentalis Pharmaceuticals Inc
ZNTL
|
SELL |
$4.00
Est. +30%
|
$5.70 | $1.01 (Low) |
Target Met
|
$1.76
+69.1%
|
| May 09, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$8.00
Est. +233%
|
$2.40 | $1.52 |
Miss
|
$2.35
-2.1%
|
| Apr 11, 2024 |
Alpine Immune Sciences Inc
ALPN
|
BUY |
$65.00
Est. +38%
|
$47.04 | $65.00 |
Bullseye Hit (±1%)
|
$64.97
+38.1%
|
| Apr 08, 2024 |
Black Diamond Therapeutics Inc
BDTX
|
BUY |
$16.00
Est. +216%
|
$5.06 | $6.75 |
Miss
|
$1.90
-62.5%
|
| Oct 23, 2023 |
Arvinas Inc
ARVN
|
BUY |
$24.00
Est. +62%
|
$14.83 | $34.09 |
Target Met
|
$7.42
-50.0%
|
| May 16, 2022 |
Harpoon Therapeutics Inc
HARP
|
SELL |
$7.00
Est. +97%
|
$231.57 | - | - |
$23.01
+90.1%
|
| May 11, 2022 |
Arcus Biosciences Inc
RCUS
|
BUY |
$42.00
Est. +75%
|
$24.01 | - | - |
$19.30
-19.6%
|
| Feb 18, 2022 |
Arvinas Inc
ARVN
|
BUY |
$98.00
Est. +42%
|
$69.02 | - | - |
$7.42
-89.2%
|
| Nov 19, 2021 |
Gilead Sciences, Inc.
GILD
|
SELL |
$67.00
Est. +0%
|
$67.14 | - | - |
$174.48
-159.9%
|
Foghorn Therapeutics Inc
FHTX
Oct 02, 2026
Signal & Target
SELL
$2.00
Start Price
$2.92
Best Price (1Y)
$1.80
Current Price
$2.10
Return
+28.1%
Compass Therapeutics Inc
CMPX
Sep 22, 2026
Signal & Target
SELL
$1.00
Start Price
$1.24
Best Price (1Y)
$0.73
Current Price
$0.78
Return
+37.5%
Pyxis Oncology Inc
PYXS
Sep 10, 2026
Signal & Target
BUY
$8.00
Start Price
$3.38
Best Price (1Y)
$3.52
Current Price
$1.66
Return
-50.9%
Replimune Group Inc
REPL
Aug 07, 2026
Signal & Target
BUY
$19.00
Start Price
$12.86
Best Price (1Y)
$21.26
Current Price
$20.69
Return
+60.9%
Arvinas Inc
ARVN
Aug 05, 2026
Signal & Target
BUY
$12.00
Start Price
$9.00
Best Price (1Y)
$9.74
Current Price
$7.42
Return
-17.6%
Monte Rosa Therapeutics Inc
GLUE
Aug 03, 2026
Signal & Target
BUY
$27.00
Start Price
$16.17
Best Price (1Y)
$17.13
Current Price
$10.82
Return
-33.1%
Replimune Group Inc
REPL
Jul 31, 2026
Signal & Target
BUY
$12.00
Start Price
$5.41
Best Price (1Y)
$21.26
Current Price
$20.69
Return
+282.4%
Revolution Medicines Inc
RVMD
Jul 23, 2026
Signal & Target
BUY
$192.10
Start Price
$190.94
Best Price (1Y)
$224.31
Current Price
$199.70
Return
+4.6%
Pyxis Oncology Inc
PYXS
May 05, 2026
Signal & Target
BUY
$6.00
Start Price
$1.76
Best Price (1Y)
$4.12
Current Price
$1.66
Return
-5.7%
Tyra Biosciences Inc
TYRA
Feb 13, 2026
Signal & Target
BUY
$53.00
Start Price
$30.10
Best Price (1Y)
$40.65
Current Price
$21.53
Return
-28.5%
Tyra Biosciences Inc
TYRA
Dec 16, 2025
Signal & Target
BUY
$37.00
Start Price
$22.11
Best Price (1Y)
$40.65
Current Price
$21.53
Return
-2.6%
Cullinan Therapeutics Inc
CGEM
Dec 09, 2025
Signal & Target
BUY
$34.00
Start Price
$12.18
Best Price (1Y)
$23.19
Current Price
$12.49
Return
+2.5%
IGM Biosciences Inc
IGMS
Aug 15, 2024
Signal & Target
BUY
$25.00
Start Price
$8.72
Best Price (1Y)
$22.50
Current Price
$1.27
Return
-85.4%
Tango Therapeutics Inc
TNGX
Aug 08, 2024
Signal & Target
BUY
$13.00
Start Price
$8.72
Best Price (1Y)
$12.02
Current Price
$23.18
Return
+165.8%
Revolution Medicines Inc
RVMD
Jul 15, 2024
Signal & Target
BUY
$59.00
Start Price
$47.01
Best Price (1Y)
$62.40
Current Price
$199.70
Return
+324.8%
Zentalis Pharmaceuticals Inc
ZNTL
Jun 18, 2024
Signal & Target
SELL
$4.00
Start Price
$5.70
Best Price (1Y)
$1.01
Current Price
$1.76
Return
+69.1%
CytomX Therapeutics Inc
CTMX
May 09, 2024
Signal & Target
BUY
$8.00
Start Price
$2.40
Best Price (1Y)
$1.52
Current Price
$2.35
Return
-2.1%
Alpine Immune Sciences Inc
ALPN
Apr 11, 2024
Signal & Target
BUY
$65.00
Start Price
$47.04
Best Price (1Y)
$65.00
Current Price
$64.97
Return
+38.1%
Black Diamond Therapeutics Inc
BDTX
Apr 08, 2024
Signal & Target
BUY
$16.00
Start Price
$5.06
Best Price (1Y)
$6.75
Current Price
$1.90
Return
-62.5%
Arvinas Inc
ARVN
Oct 23, 2023
Signal & Target
BUY
$24.00
Start Price
$14.83
Best Price (1Y)
$34.09
Current Price
$7.42
Return
-50.0%
Harpoon Therapeutics Inc
HARP
May 16, 2022
Signal & Target
SELL
$7.00
Start Price
$231.57
Best Price (1Y)
-
Current Price
$23.01
Return
+90.1%
Arcus Biosciences Inc
RCUS
May 11, 2022
Signal & Target
BUY
$42.00
Start Price
$24.01
Best Price (1Y)
-
Current Price
$19.30
Return
-19.6%
Arvinas Inc
ARVN
Feb 18, 2022
Signal & Target
BUY
$98.00
Start Price
$69.02
Best Price (1Y)
-
Current Price
$7.42
Return
-89.2%
Gilead Sciences, Inc.
GILD
Nov 19, 2021
Signal & Target
SELL
$67.00
Start Price
$67.14
Best Price (1Y)
-
Current Price
$174.48
Return
-159.9%